Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07527026 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer

Name: A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer — clinical trial record (NCT07527026)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorChinese PLA General Hospital

Started2026-02-01

View on ClinicalTrials.gov ↗

Chinese PLA General Hospital

193 trials monitored

See 4 trials at risk

Colorectal Cancer

2,904 trials monitored

See 127 trials at risk

In pMMR/MSS locally advanced rectal cancer, can the innovative "chemo-immunotherapy induction + LCRT + chemo-immunotherapy consolidation" approach significantly improve the complete response rate and create opportunities for organ preservation?

Trial Details

NCT Number	NCT07527026
Lead Sponsor	Chinese PLA General Hospital
Conditions	Locally Advanced Rectal Cancer
Enrollment	44 participants
Start Date	2026-02-01
Primary Completion	2028-02-01 (estimated)
Study Completion	2029-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-14